Evaluating the Utility of a Nanoscale Flow Cytometer for Detection of Surface Proteins on HIV and Extracellular Vesicles

This study demonstrates that the CytoFLEX nano flow cytometer offers significantly improved scatter sensitivity compared to the conventional CytoFLEX S, enabling the detection of smaller viruses and previously undetectable extracellular vesicles within HIV preparations while maintaining comparable performance for surface protein labeling.

The Gist

Imagine you are trying to find tiny, invisible specks of dust floating in a room. For a long time, the only "flashlights" scientists had (the old flow cytometers) were too weak to see anything smaller than a grain of sand. Viruses and tiny bubbles in our blood (called extracellular vesicles) are much smaller than that—more like individual grains of pollen. Because they were so small, they just blended into the background noise, making them impossible to study individually.

This paper is about testing a brand-new, super-powered flashlight called the CytoFLEX nano to see if it can finally spot these tiny particles, and how it compares to the older, reliable flashlight called the CytoFLEX S.

Here is the breakdown of their findings using simple analogies:

1. The "Flashlight" Test (Seeing the Invisible)

The researchers first tested both flashlights on a set of tiny, known-size beads (like a ruler for dust).

• The Old Flashlight (CytoFLEX S): It could see the big beads, but the tiny ones (smaller than a grain of sand) were lost in the static. It was like trying to see a firefly in a foggy night with a dim bulb.
• The New Flashlight (CytoFLEX nano): This one was a game-changer. It was 50 times better at separating the signal from the noise. It could clearly see the tiny beads that the old one missed completely. It's like switching from a dim bulb to a high-definition laser pointer; suddenly, the tiny particles pop out clearly against the dark background.

2. The "HIV Detective" Mission

The team used HIV as their main target because it's a well-known "criminal" in the body. They wanted to see if the new flashlight could spot specific "wanted posters" (proteins) stuck to the surface of the virus.

• The Result: Both flashlights were good at finding the wanted posters on the big HIV viruses. They were equally good at this specific job.
• The Twist: However, the new flashlight (CytoFLEX nano) found something the old one missed: Imposters.

3. The "Imposter" Problem (Viruses vs. Vesicles)

Here is where it gets interesting. When HIV is made in a lab, it doesn't come alone. It comes with a crowd of tiny, empty bubbles called Extracellular Vesicles (EVs). These bubbles look almost exactly like the virus, but they are harmless.

• The Old Flashlight: It saw the virus and the bubbles as one big, blurry blob. It couldn't tell them apart.
• The New Flashlight: Because it is so sensitive, it could separate the "real virus" from the "empty bubbles." It found a whole hidden population of these bubbles that were carrying specific markers (like tetraspanins) that the old machine simply couldn't see. It's like a security guard who can finally tell the difference between a VIP guest and a person wearing a fake badge, whereas before, they looked identical.

4. The "Rainbow" Glitch (The Downside)

So, is the new flashlight perfect? Not quite.

• The Problem: The new flashlight is so powerful that it sometimes causes a "color bleed." Imagine you are looking at a red balloon and a green balloon. With the new flashlight, the red light is so bright it spills over and makes the green balloon look slightly red, too.
• The Consequence: When scientists tried to look at two different things at once (like the virus and a specific protein), the colors got mixed up on the new machine. The old machine, while weaker, was actually better at keeping the colors separate and distinct.
• The Speed: The new machine is also slower. It takes its time to look at every single particle carefully, whereas the old machine can scan a crowd much faster.

The Big Takeaway

Think of these two machines as a Swiss Army Knife (the old CytoFLEX S) and a High-Precision Microscope (the new CytoFLEX nano).

• If you need to scan a huge crowd quickly or look at many different colors at once, the Swiss Army Knife is still your best friend.
• If you need to find the tiniest, most elusive particles or separate very similar-looking bubbles from viruses, the Microscope is unbeatable.

In short: The new machine doesn't replace the old one; it complements it. By using both together, scientists can finally get a complete picture of the viral world, spotting not just the viruses, but the hidden "bubbles" that travel with them, which could change how we understand and treat diseases like HIV.

Technical Summary

1. Problem Statement

Flow virometry (FV), the application of flow cytometry to viruses, has historically been limited by the inability of conventional instruments to detect particles smaller than ~300 nm due to high background noise in light scattering. While strategies such as fluorescent triggering or bead-based methods have been used, they often require complex sample preparation. Although conventional instruments like the Beckman Coulter CytoFLEX S have improved small-particle detection, a dedicated nanoscale instrument, the CytoFLEX nano (released in 2024), was marketed to detect particles as small as 40 nm. However, its performance relative to conventional platforms for virus characterization, specifically regarding surface protein labeling and the differentiation of viruses from extracellular vesicles (EVs), had not been rigorously evaluated.

2. Methodology

The study employed a comparative approach using two instruments: the conventional CytoFLEX S and the dedicated CytoFLEX nano.

• Instrument Calibration & Sensitivity Testing:
  • NIST-traceable beads: Beads ranging from 40 nm to 400 nm were used to assess scatter sensitivity and signal-to-noise ratios (S/N).
  • Virus Stocks: Human Immunodeficiency Virus (HIV, strain IIIB), Human Coronavirus (HCoV-229E), and HCoV-OC43 were analyzed via light scatter alone.
• Fluorescence Labeling (HIV):
  • Virion-Incorporated Proteins: HIV virions produced in H9 T-cells were stained with PE- and BV421-conjugated antibodies targeting cellular proteins CD38 and CD44.
  • Dual Labeling: Simultaneous staining of CD38 and CD44 was performed to assess multi-color capabilities.
  • EV Differentiation: HIV stocks were labeled with antibodies against tetraspanins (CD9, CD81, CD63, CD82) to identify EV contamination.
  • GFP-Tagged Constructs: A GFP-tagged HIV construct (GFP inserted between capsid and matrix) was used to distinguish true virions (GFP+) from EVs (GFP-). These were stained with the anti-Env antibody PGT128 (PE-conjugated) and tetraspanin antibodies.
• Acquisition Parameters:
  • CytoFLEX S: Standard flow rate (10 µL/min), medium/fast acquisition.
  • CytoFLEX nano: Reduced flow rate (1 µL/min) to enhance sensitivity, utilizing violet side scatter (VSSC1) triggering.
• Data Analysis: Data were calibrated using FCMPASS software to estimate particle size in nanometers and analyzed using FlowJo.

3. Key Contributions

• Direct Comparison: This is the first study to directly compare the CytoFLEX nano against the CytoFLEX S for flow virometry applications involving both light scatter and surface protein fluorescence.
• EV/Virion Discrimination: The study demonstrates a novel application of the CytoFLEX nano to resolve distinct populations of EVs within virus preparations that are invisible to conventional cytometers.
• Spectral Analysis: It provides critical data on the spectral overlap issues (specifically between GFP and PE/BV421 channels) inherent to the CytoFLEX nano's optical configuration compared to the S model.

4. Key Results

• Scatter Sensitivity:

  • The CytoFLEX nano exhibited a ~50-fold higher signal-to-noise ratio compared to the CytoFLEX S for 100 nm beads.
  • Detection Limits: The nano instrument successfully resolved bead populations of 40, 50, and 70 nm, which were undetectable on the CytoFLEX S.
  • Virus Detection: While HIV (~120 nm) was detectable on both, the nano instrument provided significantly clearer resolution for smaller coronaviruses (HCoV-229E), which overlapped with background noise on the CytoFLEX S.

• Surface Protein Labeling:

  • Both instruments successfully detected CD38 and CD44 on HIV virions.
  • The CytoFLEX nano showed a larger dynamic range for scatter, revealing a distinct population of antibody-labeled EVs and background aggregates that were below the threshold on the CytoFLEX S.
  • Fluorescence intensity (PE) was comparable, though the CytoFLEX S recorded higher raw PE values (likely due to higher gain settings), while the nano required lower gain to avoid saturation.

• Differentiation of Virions vs. EVs:

  • Tetraspanins: The CytoFLEX nano revealed a distinct population of tetraspanin-positive (CD9, CD81) EVs within HIV stocks that were completely unresolved on the CytoFLEX S.
  • GFP/Env Co-staining: Using GFP-tagged HIV, the study identified Env-positive particles that lacked GFP (indicating EVs carrying viral envelope).
  • Spectral Spillover: A major limitation of the CytoFLEX nano was identified: its co-linear laser configuration caused significant spectral spillover between GFP and PE channels. This made dual-color analysis (e.g., GFP + PE-Env) difficult without compensation, whereas the CytoFLEX S provided cleaner spectral separation.

• Throughput:

  • The CytoFLEX nano has a 10-fold slower flow rate (1 µL/min vs. 10 µL/min) and requires longer automated cleaning cycles between samples (4 minutes vs. 45 seconds), making it less suitable for high-throughput screening compared to the CytoFLEX S.

5. Significance and Conclusion

The study concludes that the CytoFLEX nano represents a significant advancement in flow virometry, offering markedly improved scatter sensitivity that enables the detection of sub-100 nm particles and the resolution of heterogeneous populations (virions vs. EVs) previously indistinguishable.

• Complementary Utility: The two platforms are best used in tandem. The CytoFLEX S is superior for high-throughput, multi-color surface protein profiling with minimal spectral spillover. The CytoFLEX nano is essential for detecting small particles, resolving EV contamination in viral stocks, and analyzing low-abundance scatter signals.
• Future Directions: The ability to distinguish EVs from virions without magnetic beads or complex purification opens new avenues for studying virus-vesicle heterogeneity, defective viral particles, and the role of EVs in viral pathogenesis. However, the spectral limitations of the nano instrument necessitate careful experimental design and compensation strategies for multi-color assays.